AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $513,000 | -38.6% | 51,000 | -24.4% | 0.72% | -19.0% |
Q1 2022 | $836,000 | -80.6% | 67,500 | -64.2% | 0.88% | -71.6% |
Q4 2021 | $4,311,000 | +8.2% | 188,500 | +4.7% | 3.12% | +51.0% |
Q3 2021 | $3,983,000 | +89.1% | 180,000 | +10.8% | 2.06% | +90.8% |
Q2 2021 | $2,106,000 | – | 162,500 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |